Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139

Latov, Norman

doi:10.3390/microorganisms11030640

Open AccessCorrection

Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139

by

Norman Latov

Department of Neurology, Weill Cornell Medicine, 1305 York Ave, Ste 217, New York, NY 10021, USA

Microorganisms 2023, 11(3), 640; https://doi.org/10.3390/microorganisms11030640

Submission received: 27 December 2022 / Accepted: 16 January 2023 / Published: 2 March 2023

(This article belongs to the Special Issue Recent Advances in Campylobacter jejuni and Helicobacter pylori)

Download Versions Notes

The authors wish to make the following corrections to this paper [1]:

In the last paragraph of Section 9, Immune Mechanisms and Induction of Ant-Ganglioside Antibodies, the author mistakenly wrote: “As an example, Hirano and colleagues [84] reported on a family with Cj infection, in which IgG but IgM anti-ganglioside antibodies were associated with GBS.”

The correct version should be as follows:

“As an example, Rees and colleagues [39] reported that some patients with uncomplicated Cj infection without neuropathy developed IgM but not IgG anti-ganglioside antibodies.”

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.

Reference

Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139. [Google Scholar] [CrossRef]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Latov, N. Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139. Microorganisms 2023, 11, 640. https://doi.org/10.3390/microorganisms11030640

AMA Style

Latov N. Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139. Microorganisms. 2023; 11(3):640. https://doi.org/10.3390/microorganisms11030640

Chicago/Turabian Style

Latov, Norman. 2023. "Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139" Microorganisms 11, no. 3: 640. https://doi.org/10.3390/microorganisms11030640

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI